NCT03197415 is a NA clinical trial of Platelet-rich plasma in Discogenic Pain, sponsored by Pei-Yuan Lee, MD.

Who is sponsoring NCT03197415?

NCT03197415 is sponsored by Pei-Yuan Lee, MD.

What drugs are being tested in NCT03197415?

Interventions in NCT03197415: Platelet-rich plasma.

What condition does NCT03197415 study?

NCT03197415 studies Discogenic Pain, Platelet-rich Plasma.

Is NCT03197415 still recruiting?

NCT03197415 is currently completed. Last updated 6 September 2019.

Last reviewed 2019-09-06 · How we verify

NCT03197415

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet-rich Plasma for Low Back Pain

Completed NA Last updated 6 September 2019

What this trial tests

NA trial testing Platelet-rich plasma in Discogenic Pain in 30 participants. Completed in 25 March 2019.

Timeline

22 April 2016

Primary endpoint
25 March 2019

25 March 2019

Quick facts

Lead sponsor	Pei-Yuan Lee, MD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	22 April 2016
Primary completion	25 March 2019
Estimated completion	25 March 2019
Sites	1 location across Taiwan

Drugs / interventions tested

Platelet-rich plasma

Conditions studied

Discogenic Pain — all drugs for Discogenic Pain →
Platelet-rich Plasma — all drugs for Platelet-rich Plasma →

Sponsor

Pei-Yuan Lee, MD

Who can join

Adults 20 to 60, any sex, with Discogenic Pain or Platelet-rich Plasma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effect of platelet-rich plasma (PRP) on discogenic low back pain by comparing the pre- and post-interventional outcomes in patients receiving intradiscal injection of autologous PRP.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Intervertebral Disc Degeneration: Biomaterials and Tissue Engineering Strategies toward Precision Medicine.
Mohd Isa IL, Mokhtar SA, Abbah SA, Fauzi MB, et al · · 2022 · cited 101× · PMID 35373924 · DOI 10.1002/adhm.202102530
Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain.
Mohammed S, Yu J. · · 2018 · cited 43× · PMID 29732431 · DOI 10.21037/jss.2018.03.04

Verify or expand the search:

Other trials of Platelet-rich plasma

Trials testing the same drug.

NCT07103551 — Evaluation of the Efficacy of Injectable Platelet-rich Plasma in Tooth Movement Acceleration With Clear Aligner · Phase 3 · not yet recruiting
NCT06372600 — Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Ten · NA · not yet recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT05329116 — Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis · NA · unknown
NCT05214924 — Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management · Phase 2, PHASE3 · enrolling by invitation

Other recruiting trials for Discogenic Pain

Currently open trials in the same condition.

NCT06345690 — VIA Disc NP Registry 3.0 · recruiting
NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting

Other Pei-Yuan Lee, MD trials

Trials by the same sponsor.

NCT03197441 — Platelet Rich Plasma for Knee Osteoarthritis · NA · completed
NCT03176641 — Platelet-rich Plasma for Meniscus Repair · NA · completed
NCT03197428 — Platelet-rich Plasma for Chronic Lateral Ankle Instability · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03197415 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pei-Yuan Lee, MD
Last refreshed: 6 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03197415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing